Puk16 - Cost-Effectiveness of Tolvaptan in Canadian Patients With Autosomal Polycystic Kidney Disease: An Adaptation of the Adpkd Outcomes Model
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2814
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV